Christopher Michael Wade - 18 Mar 2026 Form 3 Insider Report for Cellebrite DI Ltd. (CLBT)

Reporting relationship: Chief Technology Officer
Issuer ticker: CLBT
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 18 Mar 2026, 08:08:05 UTC
Source filing: View source filing
Reporting owner signature: /s/ Christopher Wade

Key filing fact

Christopher Michael Wade filed Form 3 for Cellebrite DI Ltd. (CLBT) on 18 Mar 2026.

Key facts

This page summarizes Christopher Michael Wade's Form 3 filing for Cellebrite DI Ltd. (CLBT).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 18 Mar 2026, 08:08.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002109088 Primary reporting owner

Wade Christopher Michael

Relationship: Chief Technology Officer
Address: 94 SHLOMO SHMELZER ROAD, PETAH TIKVA, ISRAEL
Signature: /s/ Christopher Wade
Signature date: 18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLBT holding

Ordinary shares, par value NIS 0.00001 ("Ordinary Shares")

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 610,453
Date: 18 Mar 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Includes 31,593 Ordinary Shares that are represented by restricted share units ("RSUs") that were granted on February 10, 2026 and vest as follows: 7,905 vest on the first anniversary of the grant date and 1,974 vest every three months thereafter through February 10, 2030. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.